DARE
Price
$3.11
Change
-$0.09 (-2.81%)
Updated
Jun 9, 02:10 PM (EDT)
Capitalization
28.32M
RIGL
Price
$21.47
Change
-$0.02 (-0.09%)
Updated
Jun 9, 02:59 PM (EDT)
Capitalization
384.08M
Interact to see
Advertisement

DARE vs RIGL

Header iconDARE vs RIGL Comparison
Open Charts DARE vs RIGLBanner chart's image
Dare Bioscience
Price$3.11
Change-$0.09 (-2.81%)
Volume$254
Capitalization28.32M
Rigel Pharmaceuticals
Price$21.47
Change-$0.02 (-0.09%)
Volume$200
Capitalization384.08M
DARE vs RIGL Comparison Chart
Loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DARE vs. RIGL commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a Buy and RIGL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (DARE: $2.87 vs. RIGL: $19.19)
Brand notoriety: DARE and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 106% vs. RIGL: 68%
Market capitalization -- DARE: $28.32M vs. RIGL: $384.08M
DARE [@Biotechnology] is valued at $28.32M. RIGL’s [@Biotechnology] market capitalization is $384.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, RIGL is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 3 TA indicator(s) are bullish while RIGL’s TA Score has 6 bullish TA indicator(s).

  • DARE’s TA Score: 3 bullish, 6 bearish.
  • RIGL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than DARE.

Price Growth

DARE (@Biotechnology) experienced а -0.69% price change this week, while RIGL (@Biotechnology) price change was -8.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.68%. For the same industry, the average monthly price growth was +19.57%, and the average quarterly price growth was +6.76%.

Industries' Descriptions

@Biotechnology (+10.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($384M) has a higher market cap than DARE($28.3M). RIGL has higher P/E ratio than DARE: RIGL (10.28) vs DARE (0.10). RIGL YTD gains are higher at: 14.090 vs. DARE (-8.013). RIGL has higher annual earnings (EBITDA): 28.5M vs. DARE (-23.19M). RIGL has more cash in the bank: 77.3M vs. DARE (11.2M). DARE has less debt than RIGL: DARE (1.4M) vs RIGL (60M). RIGL has higher revenues than DARE: RIGL (179M) vs DARE (1.88M).
DARERIGLDARE / RIGL
Capitalization28.3M384M7%
EBITDA-23.19M28.5M-81%
Gain YTD-8.01314.090-57%
P/E Ratio0.1010.281%
Revenue1.88M179M1%
Total Cash11.2M77.3M14%
Total Debt1.4M60M2%
FUNDAMENTALS RATINGS
DARE vs RIGL: Fundamental Ratings
DARE
RIGL
OUTLOOK RATING
1..100
311
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8247
P/E GROWTH RATING
1..100
78100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RIGL's Valuation (78) in the Biotechnology industry is in the same range as DARE (83). This means that RIGL’s stock grew similarly to DARE’s over the last 12 months.

RIGL's Profit vs Risk Rating (93) in the Biotechnology industry is in the same range as DARE (100). This means that RIGL’s stock grew similarly to DARE’s over the last 12 months.

RIGL's SMR Rating (100) in the Biotechnology industry is in the same range as DARE (100). This means that RIGL’s stock grew similarly to DARE’s over the last 12 months.

RIGL's Price Growth Rating (47) in the Biotechnology industry is somewhat better than the same rating for DARE (82). This means that RIGL’s stock grew somewhat faster than DARE’s over the last 12 months.

DARE's P/E Growth Rating (78) in the Biotechnology industry is in the same range as RIGL (100). This means that DARE’s stock grew similarly to RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DARERIGL
RSI
ODDS (%)
N/A
Bearish Trend 13 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 13 days ago
76%
Bearish Trend 13 days ago
88%
Momentum
ODDS (%)
Bearish Trend 13 days ago
76%
Bullish Trend 13 days ago
80%
MACD
ODDS (%)
Bearish Trend 13 days ago
77%
Bullish Trend 13 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
79%
Bearish Trend 13 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 13 days ago
77%
Bearish Trend 13 days ago
86%
Advances
ODDS (%)
Bullish Trend 22 days ago
76%
Bullish Trend 20 days ago
83%
Declines
ODDS (%)
Bearish Trend 29 days ago
82%
Bearish Trend 27 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 13 days ago
81%
Bearish Trend 13 days ago
86%
Aroon
ODDS (%)
Bearish Trend 13 days ago
73%
Bullish Trend 13 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with RIGL. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+2.50%
RIGL - DARE
88%
Closely correlated
-2.19%
CLNN - DARE
88%
Closely correlated
+0.76%
HOOK - DARE
87%
Closely correlated
-0.32%
PHIO - DARE
81%
Closely correlated
+16.96%
AZTR - DARE
78%
Closely correlated
-3.45%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-2.19%
CLNN - RIGL
92%
Closely correlated
+0.76%
DARE - RIGL
88%
Closely correlated
+2.50%
PHIO - RIGL
84%
Closely correlated
+16.96%
AZTR - RIGL
84%
Closely correlated
-3.45%
IMRN - RIGL
82%
Closely correlated
-6.22%
More